Bringing the fundamentals into focus…
Back to Krystal Biotech, Inc.
How Krystal Biotech, Inc. stacks up
KRYS · against 1,335 other Healthcare companies
Profitability
94/ 100
Near the top of its peers.
Ranked #75 of 1,336 · scores higher than 94% of peers
Bars: peers in each 10-point band of the profitability score141 peers with a profitability score of 90–100, including KRYS · Click a bar to see the companies
Why profitability scores 94?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin, return on assets and return on invested capital, which are stronger than most Healthcare peers.
- a higher return on invested capital: stronger than 82% of peers. Return on invested capital: 16.8% vs peer median 4.7%
- a higher return on assets: stronger than 96% of peers. Return on assets: 16.1% vs peer median 1.7%
- a wider operating margin: stronger than 98% of peers. Operating margin: 44.9% vs peer median 7.1%
Metric by metric
Position: dot = KRYS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KRYS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 16.8% | 4.7% | 82% | 33% | |
| Operating marginHigher is better · 1,251 reported | 44.9% | 7.1% | 98% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 16.1% | 1.7% | 96% | 33% | |
| Return on equityHigher is better · 1,252 reported | 20.1% | 3.2% | 89% | Context only | |
| Gross marginHigher is better · 1,394 reported | 94.6% | 45.9% | 96% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around KRYS| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 75 | 179.7B INR (≈$2.2B) | 94 | 74 | |
| 75 | 27.5B NZD (≈$16.5B) | 94 | 69 | |
| 75 | 2.6B USD | 94 | 66 | |
| 75 | 155.7B USD | 94 | 64 | |
| 75 | 9.0B USD | 94 | 78 | |
| 75 | 921.9B INR (≈$11.1B) | 94 | 82 | |
| 75 | 353M EUR (≈$388M) | 94 | 77 | |
| 75 | 302.7B USD | 94 | 63 | |
| 75 | 2.3B USD | 94 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score